PB2089: ALGORITHM FOR SEVERE COVID-19 RISK STRATIFICATION DEPENDING MONOCLONAL ANTI-CD20 ANTIBODIES TREATMENT DURATION IN NON-HODGKIN LYMPHOMA PATIENTS.

Detalles Bibliográficos
Autores principales: Sychevskaya, K., Kravchenko, S., Babaeva, F., Misyurina, A., Korneeva, A., Abdulpatahov, A., Abdurashidova, R., Keniaykina, A., Sarakaeva, Z., Fastova, E., Gorenkova, L., Nesterova, E., Mangasarova, Y., Bagova, M., Margolin, O., Magomedova, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431539/
http://dx.doi.org/10.1097/01.HS9.0000851188.53364.fc

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431539/
http://dx.doi.org/10.1097/01.HS9.0000851188.53364.fc

Ejemplares similares